Case report: Bevacizumab-induced cerebrovascular events: a case series report and literature review
In clinical use, bevacizumab has improved the overall survival (OS) and progression-free survival (PFS) of malignant solid tumors, and the safe use of bevacizumab has gradually become the mainstream direction of clinical, nursing and pharmaceutical research. Bevacizumab is a humanized anti-VEGF drug...
Saved in:
Main Authors: | Ke Chen, Boyang Jiang, Huiping Yan, Liu Yang, Zheling Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1395129/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Atezolizumab plus bevacizumab in patients with unresectable or metastatic mucosal melanoma: 3‐year survival update and multi‐omics analysis
by: Jie Dai, et al.
Published: (2025-01-01) -
Cerebrovascular Accidents After Orthotopic Liver Transplantation in Patients with Hepatopulmonary Syndrome: A Case Series
by: Steffi K. Chan, et al.
Published: (2024-12-01) -
Three effective cases of transcatheter arterial embolization after atezolizumab and bevacizumab treatment for hepatocellular carcinoma: a case report
by: Koji Rinka, et al.
Published: (2025-01-01) -
To evaluate the efficacy of subconjunctival bevacizumab injection in vascular pterygium before surgical excision in preventing recurrence comparing with bare sclera technique
by: Nusrat Shaheen, et al.
Published: (2025-01-01) -
Efficacy of Sub-Conjunctival Injection of Mitomycin C Versus Bevacizumab in Pterygium Treatment: Pakistani Population
by: Amber khalid, et al.
Published: (2025-01-01)